|
|
||||||||
-TEA and VES in Reduction of Mouse Mammary Tumor Burden and Metastasis


* Division of Nutrition and School of Biological Sciences, University of Texas, Austin, Texas 78712
Department of Chemistry, Brock University, St. Catharines Ontario, Canada; and
Department of Cellular & Structural Biology, University of Texas Health Science Center, San Antonio, Texas 78229
To whom requests for reprints should be addressed at 3 Division of Nutrition/A2703, University of Texas at Austin, Austin, TX 787121097. E-mail: k.kline{at}mail.utexas.edu
A novel nonhydrolyzable ether derivative of RRR-
-tocopherol, RRR-
-tocopherol ether acetic acid analog [2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxyacetic acid (
-TEA)], and a hydrolyzable ester derivative RRR-
-tocopheryl succinate (vitamin E succinate; VES) inhibited BALB/c mouse 66cl-4-GFP mammary tumor cell growth in vitro and in vivo. Treatment of 66cl-4-GFP cells in culture with
-TEA or VES induced dose-dependent DNA synthesis arrest and apoptosis and inhibited colony formation. Liposomal formulations of
-TEA delivered orally or by aerosol significantly reduced subcutaneous 66cl-4-GFP tumor burden and metastasis to lung and lymph nodes. Liposomal formulations of VES delivered by aerosol significantly reduced tumor burden and lung metastasis, but not lymph node metastasis. Unlike
-TEA, VES was ineffective in reducing tumor burden and metastasis to lungs and lymph nodes when administered orally. Analyses of tumor sections showed that
-TEA delivered by either method significantly reduced tumor cell proliferation as measured by Ki67, and increased apoptosis as measured by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL), whereas VES delivered by aerosol reduced tumor cell proliferation and increased apoptosis, but not significantly. In summary, the nonhydrolyzable ether vitamin E derivative
-TEA was effective in reducing tumor burden and metastasis when delivered either by aerosol or orally, whereas the hydrolyzable ester vitamin E derivative VES was effective only when delivered by aerosol.
Key Words: vitamin E analog
-TEA RRR-
-tocopheryl succinate (VES) metastasis antitumor agents syngeneic mouse mammary cancer model
This article has been cited by other articles:
![]() |
T. Hahn, K. Fried, L. H. Hurley, and E. T. Akporiaye Orally active {alpha}-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer Mol. Cancer Ther., June 1, 2009; 8(6): 1570 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ni, T. Mai, S.-T. Pang, I. Haque, K. Huang, M. A. DiMaggio, S. Xie, N. S. James, D. Kasi, S. R. Chemler, et al. In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-{alpha}-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer Clin. Cancer Res., February 1, 2009; 15(3): 898 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hahn, L. Szabo, M. Gold, L. Ramanathapuram, L. H. Hurley, and E. T. Akporiaye Dietary Administration of the Proapoptotic Vitamin E Analogue {alpha}-Tocopheryloxyacetic Acid Inhibits Metastatic Murine Breast Cancer Cancer Res., October 1, 2006; 66(19): 9374 - 9378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |